4.6 Review

Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Genetics & Heredity

US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER)

Kathryn A. Phillips et al.

Summary: This study examined coverage considerations for genome sequencing (GS) and exome sequencing (ES) by payers. The findings suggest that payers see advantages to GS and are open to expanding its coverage, but they require more evidence to support their decision-making. The study also identified several steps to facilitate the coverage of GS, such as establishing evidence of its benefits in specific clinical scenarios and developing quality standards.

GENETICS IN MEDICINE (2022)

Review Genetics & Heredity

A systematic review of the methodological quality of economic evaluations in genetic screening and testing for monogenic disorders

Karl Johnson et al.

Summary: This systematic review examined economic evaluations of genetic screening/testing for monogenic disorders. The study found substantial variations in modeling approaches, reporting detail, and sophistication among the identified studies. Many studies lacked sufficient detail for replication and justification of modeling assumptions. Sensitivity analysis was commonly conducted, but meta-analysis, systematic reviews, and calibration were rarely used. The study concluded by providing recommendations for improvement in the economic evaluation of genetic screening/testing.

GENETICS IN MEDICINE (2022)

Article Economics

To be or not to be: Future lives in economic evaluation

Jeroen Luyten et al.

Summary: This study suggests making a distinction between necessary and potential future lives in Health Technology Assessment, with necessary lives to be included. This rule offers intuitive solutions within the HTA framework and changes the cost-effectiveness of several interventions.

HEALTH ECONOMICS (2022)

Article Genetics & Heredity

Diagnosing newborns with suspected mitochondrial disorders: an economic evaluation comparing early exome sequencing to current typical care

Samuel A. Crawford et al.

Summary: The study suggests that trio and singleton exome sequencing are cost-effective and cost-minimizing alternatives to current typical care for diagnosing newborns with suspected severe mitochondrial disorders. Diagnostic probabilities and NICU length-of-stay are the most sensitive model parameters. In base case analysis, trio exome sequencing shows the highest incremental net monetary benefit, and probabilistic sensitivity analysis demonstrates that trio exome sequencing has the highest likelihood of being cost-effective at a willingness-to-pay of $200,000.

GENETICS IN MEDICINE (2021)

Review Genetics & Heredity

The clinical utility of exome and genome sequencing across clinical indications: a systematic review

Salma Shickh et al.

Summary: Exome/genome sequencing shows higher diagnostic yield compared to standard genetic tests, especially in neurological and acute indications. Diagnoses trigger various clinical management changes, but there is significant heterogeneity in study procedures and outcomes, limiting the certainty of available evidence for decision-making.

HUMAN GENETICS (2021)

Review Genetics & Heredity

Next-Generation Sequencing in Newborn Screening: A Review of Current State

Ziga I. Remec et al.

Summary: Newborn screening was introduced in the 1960s, and has expanded over time with the advancement of technology, particularly high-throughput sequencing. Genomic sequencing is now widely used in clinical applications, including newborn screening, but has also raised various concerns and challenges.

FRONTIERS IN GENETICS (2021)

Review Pediatrics

The Use of Whole Genome and Exome Sequencing for Newborn Screening: Challenges and Opportunities for Population Health

Audrey C. Woerner et al.

Summary: Newborn screening aims to reduce the clinical impact of diseases on newborns, with advancements in technology allowing for rapid expansion of screening capabilities to potentially identify all genetic disorders in newborns at the optimal time.

FRONTIERS IN PEDIATRICS (2021)

Review Medicine, General & Internal

Principles of Genomic Newborn Screening Programs A Systematic Review

Lilian Downie et al.

Summary: Genomic newborn screening (gNBS) is crucial for optimizing the health and well-being of children and families, requiring evidence-based and beneficial programs. Key factors include ensuring equitable access, providing appropriate educational materials, and flexible informed consent. Transparency in the gene selection process is essential for testing, ensuring that parents value predictability over actionability.

JAMA NETWORK OPEN (2021)

Article Obstetrics & Gynecology

Exome Sequencing for Prenatal Detection of Genetic Abnormalities in Fetal Ultrasound Anomalies: An Economic Evaluation

Shahela S. Kodabuckus et al.

FETAL DIAGNOSIS AND THERAPY (2020)

Review Genetics & Heredity

Clinical utility of genomic sequencing: a measurement toolkit

Robin Z. Hayeems et al.

NPJ GENOMIC MEDICINE (2020)

Article Pediatrics

The BabySeq project: implementing genomic sequencing in newborns

Ingrid A. Holm et al.

BMC PEDIATRICS (2018)

Review Biochemistry & Molecular Biology

Economic evaluation of genomic sequencing in the paediatric population: a critical review

Khurshid Alam et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2018)

Review Genetics & Heredity

Cost-effectiveness analyses of genetic and genomic diagnostic tests

Katherine Payne et al.

NATURE REVIEWS GENETICS (2018)

Article Multidisciplinary Sciences

Precision medicine screening using whole-genome sequencing and advanced imaging to identify disease risk in adults

Bradley A. Perkins et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Medicine, General & Internal

Sequencing of Circulating Cell-free DNA during Pregnancy

Diana W. Bianchi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Pediatrics

Newborn Sequencing in Genomic Medicine and Public Health

Jonathan S. Berg et al.

PEDIATRICS (2017)

Article Economics

Using Cost-Effectiveness Analysis to Address Health Equity Concerns

Richard Cookson et al.

VALUE IN HEALTH (2017)

Article Genetics & Heredity

Genomic newborn screening: public health policy considerations and recommendations

Jan M. Friedman et al.

BMC MEDICAL GENOMICS (2017)

Review Medicine, General & Internal

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine

Gillian D. Sanders et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Biochemistry & Molecular Biology

Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes

Heidi Carmen Howard et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2015)

Article Medicine, General & Internal

Assessing the value of diagnostic tests: a framework for designing and evaluating trials

Lavinia Ferrante di Ruffano et al.

BMJ-BRITISH MEDICAL JOURNAL (2012)

Article Obstetrics & Gynecology

Cost-effectiveness analysis of prenatal diagnosis: Methodological issues and concerns

AB Caughey

GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2005)